{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:44:31Z","timestamp":1792100671698,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PDC2022\u2013133780-C21"],"award-info":[{"award-number":["PDC2022\u2013133780-C21"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PDC2022\u2013133780-C22"],"award-info":[{"award-number":["PDC2022\u2013133780-C22"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021\u2013123426OB-I00"],"award-info":[{"award-number":["PID2021\u2013123426OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PRE2019\u2013088097"],"award-info":[{"award-number":["PRE2019\u2013088097"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RTI2018\u2013094734-B-C21"],"award-info":[{"award-number":["RTI2018\u2013094734-B-C21"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RTI2018\u2013094734-B-C22"],"award-info":[{"award-number":["RTI2018\u2013094734-B-C22"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RYC2018\u20130Z23971-I"],"award-info":[{"award-number":["RYC2018\u20130Z23971-I"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Department of Health","doi-asserted-by":"publisher","award":["2021 SGR 00357"],"award-info":[{"award-number":["2021 SGR 00357"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Department of Health","doi-asserted-by":"publisher","award":["2021 SGR 00881"],"award-info":[{"award-number":["2021 SGR 00881"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015755","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["RED2022\u2013134485-T"],"award-info":[{"award-number":["RED2022\u2013134485-T"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.biopha.2024.116143","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T07:47:01Z","timestamp":1705132021000},"page":"116143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Liver-targeted nanoparticles delivering nitric oxide reduce portal hypertension in cirrhotic rats"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1944-8337","authenticated-orcid":false,"given":"Meritxell","family":"Perram\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Naval\u00f3n-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7776-3300","authenticated-orcid":false,"given":"Guillermo","family":"Fern\u00e1ndez-Varo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7317-7419","authenticated-orcid":false,"given":"Alazne","family":"Moreno-Lanceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Garc\u00eda-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Faneca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Lopez de Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fornaguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2132-4138","authenticated-orcid":false,"given":"Judith","family":"Garc\u00eda-Villoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Morales-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-5911","authenticated-orcid":false,"given":"Pedro","family":"Melgar-Lesmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Borr\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9376-0214","authenticated-orcid":false,"given":"Wladimiro","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2024.116143_bib1","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3748\/wjg.v19.i11.1707","article-title":"Current concepts on the role of nitric oxide in portal hypertension","volume":"19","author":"Hu","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116143_bib2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.mayocp.2018.12.020","article-title":"Portal hypertension and related complications: diagnosis and management","volume":"94","author":"Simonetto","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.biopha.2024.116143_bib3","article-title":"Ascites and Renal Dysfunction in Liver Disease: Pathogenesis","volume":"Vol. 1","author":"Moller","year":"2005"},{"issue":"2","key":"10.1016\/j.biopha.2024.116143_bib4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0016-5085(03)00909-0","article-title":"Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats","volume":"125","author":"Morales-Ruiz","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.biopha.2024.116143_bib5","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ajg.2009.661","article-title":"NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study","volume":"105","author":"Berzigotti","year":"2010","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116143_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/092986710789957841","article-title":"Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks","volume":"17","author":"Scateana","year":"2010","journal-title":"Curr. Med Chem."},{"issue":"8","key":"10.1016\/j.biopha.2024.116143_bib7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tips.2015.05.001","article-title":"MY. Nitric oxide in liver diseases","volume":"36","author":"Iwakiri","year":"2015","journal-title":"Trends Pharm. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.116143_bib8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1665-2681(19)31436-X","article-title":"Role of nitric oxide in liver regeneration","volume":"11","author":"Carnovale","year":"2012","journal-title":"Ann. Hepatol."},{"issue":"19","key":"10.1016\/j.biopha.2024.116143_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201900849","article-title":"In vivo retargeting of poly(beta aminoester) (OM-PBAE) nanoparticles is influenced by protein corona","volume":"8","author":"Fornaguera","year":"2019","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.biopha.2024.116143_bib10","first-page":"215","article-title":"Experimental Models of Cirrhosis and Ascites in Ascites and Renal Dysfunction in Liver Disease: Pathogenesis Diagnosis and Treatment","volume":"Vol. 1","author":"Cl\u00e0ria","year":"2005"},{"issue":"9","key":"10.1016\/j.biopha.2024.116143_bib11","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.3390\/ijms22094752","article-title":"Validation of a gas chromatography-mass spectrometry method for the measurement of the redox state metabolic ratios lactate\/pyruvate and \u03b2-hydroxybutyrate\/acetoacetate in biological samples","volume":"22","author":"Wijngaard","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116143_bib12","series-title":"Cellular and Molecular Pathobiology of Cardiovascular Disease","first-page":"51","article-title":"The pathophysiology of cardiac hypertrophy and heart failure","author":"Stansfield","year":"2014"},{"issue":"3","key":"10.1016\/j.biopha.2024.116143_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2007.03.008","article-title":"Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1\u20137) levels in experimental biliary fibrosis","volume":"47","author":"Herath","year":"2007","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116143_bib14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2024.116143_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/B978-0-12-394274-6.00006-6","article-title":"Therapeutic potential of targeting SK1 in human cancers","volume":"117","author":"Alshaker","year":"2013","journal-title":"Adv. Cancer Res"},{"issue":"1-3","key":"10.1016\/j.biopha.2024.116143_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0300-483X(95)03177-H","article-title":"A. Serum amino acid changes in rats with thioacetamide-induced liver cirrhosis","volume":"106","author":"Fontana","year":"1996","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.biopha.2024.116143_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00807325","article-title":"I. Plasma amino acids in four models of experimental liver injury in rats","volume":"10","author":"Hole\u010dek","year":"1996","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.biopha.2024.116143_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-00671-1","article-title":"TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice","volume":"7","author":"Thiele","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2024.116143_bib19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10495-013-0827-5","article-title":"Hepatic apoptosis can modulate liver fibrosis through TIMP1 pathway","volume":"18","author":"Wang","year":"2013","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.biopha.2024.116143_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000025583","article-title":"Gene expression of endothelin-1 ET(A) andET(B) receptors in human cirrhosis: relationship with hepatic hemodynamics","volume":"35","author":"Leivas","year":"1998","journal-title":"J. Vasc. Res"},{"issue":"15","key":"10.1016\/j.biopha.2024.116143_bib21","doi-asserted-by":"crossref","first-page":"8897","DOI":"10.1073\/pnas.151136298","article-title":"NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension","volume":"98","author":"Fiorucci","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.biopha.2024.116143_bib22","doi-asserted-by":"crossref","first-page":"15314","DOI":"10.3390\/molecules190915314","article-title":"Organic nitrates: past, present and future","volume":"19","author":"Fran\u00e7a-Silva","year":"2014","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.biopha.2024.116143_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/ars.2015.6376","article-title":"Organic nitrate therapy, nitrate tolerance, and nitrate-induced endothelial dysfunction: emphasis on redox biology and oxidative stress","volume":"23","author":"Daiber","year":"2015","journal-title":"Antioxid. Redox Signal"},{"issue":"2","key":"10.1016\/j.biopha.2024.116143_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801359","article-title":"Poly(\u03b2-amino esters): synthesis, formulations, and their biomedical applications","volume":"8","author":"Liu","year":"2019","journal-title":"Adv. Health Mater."},{"issue":"6","key":"10.1016\/j.biopha.2024.116143_bib25","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1039\/D2NA00800A","article-title":"Unravelling the role of individual components in pBAE\/polynucleotide polyplexes in the synthesis of tailored carriers for specific applications: on the road to rational formulations","volume":"5","author":"Naval\u00f3n-L\u00f3pez","year":"2023","journal-title":"Nanoscale Adv."},{"issue":"17","key":"10.1016\/j.biopha.2024.116143_bib26","article-title":"mRNA delivery system for targeting antigen-presenting cells in vivo","volume":"7","author":"Fornaguera","year":"2018","journal-title":"Adv. Health Mater."},{"issue":"15","key":"10.1016\/j.biopha.2024.116143_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001894","article-title":"Delivery of Anti-microRNA-712 to inflamed endothelial cells using Poly(\u03b2-amino ester) nanoparticles conjugated with VCAM-1 targeting peptide","volume":"10","author":"Dosta","year":"2021","journal-title":"Adv. Health Mater."},{"issue":"44","key":"10.1016\/j.biopha.2024.116143_bib28","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1021\/ja0015388","article-title":"Degradable poly(\u03b2-amino esters): synthesis, characterization, and self-assembly with plasmid DNA","volume":"122","author":"Lynn","year":"2000","journal-title":"J. Am. Chem. Soc."},{"issue":"1Suppl","key":"10.1016\/j.biopha.2024.116143_bib29","first-page":"S121","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension","volume":"62","author":"Bosch","year":"2015","journal-title":"How Chang. Paradig. Lead. Success. N. Treat. J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116143_bib30","article-title":"Beta-blockers in cirrhosis: evidence based indications and limitations","volume":"2","author":"Rodrigues","year":"2019","journal-title":"JHEP Rep."},{"issue":"9","key":"10.1016\/j.biopha.2024.116143_bib31","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1572-0241.2007.01481.x","article-title":"Practice guidelines committee of the american association for the study of liver diseases; practice parameters committee of the american college of gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"102","author":"Garcia-Tsao","year":"2007","journal-title":"Am. J. Gastroenterol."},{"issue":"19","key":"10.1016\/j.biopha.2024.116143_bib32","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/smll.201402870","article-title":"The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension","volume":"11","author":"Duong","year":"2015","journal-title":"Small"},{"issue":"41","key":"10.1016\/j.biopha.2024.116143_bib33","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.3748\/wjg.v12.i41.6639","article-title":"Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor VPYRRO\/ NO in bile duct ligated rats","volume":"12","author":"Moal","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116143_bib34","first-page":"392","article-title":"A novel liver-targeted nitric oxide donor UDCA-Thr-NO protects against cirrhosis and portal hypertension","volume":"10","author":"Sun","year":"2018","journal-title":"Am. J. Transl. Res"},{"key":"10.1016\/j.biopha.2024.116143_bib35","series-title":"Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications","article-title":"Hydroxyproline as a biomarker in liver disease","author":"Gabr","year":"2017"},{"issue":"8","key":"10.1016\/j.biopha.2024.116143_bib36","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1021\/acs.jproteome.3c00009","article-title":"Integration of metabolomics, lipidomics, and proteomics reveals the metabolic characterization of nonalcoholic steatohepatitis","volume":"22","author":"Zhang","year":"2023","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.biopha.2024.116143_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2020.00587","article-title":"Lysine catabolism through the saccharopine pathway: enzymes and intermediates involved in plant responses to abiotic and biotic stress","volume":"11","author":"Arruda","year":"2020","journal-title":"Front Plant Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116143_bib38","article-title":"2-Aminoadipic acid (2-AAA) as a potential biomarker for insulin resistance in childhood obesity","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116143_bib39","article-title":"Nitric Oxide and Systemic and Renal Hemodynamic Disturbances in Cirrhosis","volume":"Vol 1","author":"Morales-Ruiz","year":"2005"},{"issue":"1","key":"10.1016\/j.biopha.2024.116143_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MAJ.0000000000000403","article-title":"Endothelial dysfunction in advanced liver disease","volume":"349","author":"Rockey","year":"2015","journal-title":"Am. J. Med Sci."},{"key":"10.1016\/j.biopha.2024.116143_bib41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2017.03.384","article-title":"Polymeric nanoparticles as cancer-specific DNA delivery vectors to human hepatocellular carcinoma","volume":"263","author":"Zamboni","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2024.116143_bib42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.omto.2021.04.004","article-title":"Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer","volume":"21","author":"Vaughan","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"issue":"1","key":"10.1016\/j.biopha.2024.116143_bib43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbalip.2011.06.023","article-title":"Hepatic metabolism of retinoids and disease associations","volume":"1821","author":"Shirakami","year":"2012","journal-title":"Biochim Biophys. Acta"},{"issue":"8","key":"10.1016\/j.biopha.2024.116143_bib44","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S1567-5769(01)00088-1","article-title":"The regulatory role of nitric oxide in apoptosis","volume":"1","author":"Kim","year":"2001","journal-title":"Int Immunopharmacol."},{"issue":"49","key":"10.1016\/j.biopha.2024.116143_bib45","doi-asserted-by":"crossref","first-page":"31138","DOI":"10.1074\/jbc.272.49.31138","article-title":"T R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms","volume":"272","author":"Kim","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116143_bib46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cca.2020.03.024","article-title":"COX-2 in liver fibrosis","volume":"506","author":"Yang","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.biopha.2024.116143_bib47","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.yjmcc.2005.06.012","article-title":"A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription","volume":"39","author":"Grumbach","year":"2005","journal-title":"J. Mol. Cell Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116143_bib48","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2024.116143_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.686088","article-title":"Use of precision-cut tissue slices as a translational model to study host-pathogen interaction","volume":"8","author":"Majorova","year":"2021","journal-title":"Front Vet. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.116143_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095462","article-title":"The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices","volume":"9","author":"Westra","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.116143_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejpb.2018.11.005","article-title":"siRNA-mediated protein knockdown in precision-cut lung slices","volume":"133","author":"Ruigrok","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"21","key":"10.1016\/j.biopha.2024.116143_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201906523","article-title":"Time-Resolved Quantification of Nanoparticle Uptake, Distribution, and Impact in Precision-Cut Liver Slices","volume":"16","author":"Bartucci","year":"2020","journal-title":"Small"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224000246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224000246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:52:32Z","timestamp":1792097552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224000246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":52,"alternative-id":["S0753332224000246"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116143","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver-targeted nanoparticles delivering nitric oxide reduce portal hypertension in cirrhotic rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116143"}}